These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does the antihypertensive response to angiotensin converting enzyme inhibition predict the antihypertensive response to angiotensin receptor antagonism? Stergiou GS; Skeva II; Baibas NM; Kalkana CB; Roussias LG; Mountokalakis TD Am J Hypertens; 2001 Jul; 14(7 Pt 1):688-93. PubMed ID: 11465654 [TBL] [Abstract][Full Text] [Related]
3. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998 [TBL] [Abstract][Full Text] [Related]
4. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis. Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164 [TBL] [Abstract][Full Text] [Related]
5. Comparative effects of telmisartan in the treatment of hypertension. White WB J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925 [TBL] [Abstract][Full Text] [Related]
6. Discordant responses to two classes of drugs acting on the renin-angiotensin system. Sever PS; Chang CL J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062 [TBL] [Abstract][Full Text] [Related]
7. A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy. Anantharaman R; Bhansali A; Bhadada SK; Kohli HS; Walia R; Shanmugasundar G; Jayaprakash P Indian J Med Res; 2011 Nov; 134(5):658-63. PubMed ID: 22199105 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril. Stergiou GS; Efstathiou SP; Roussias LG; Mountokalakis TD J Cardiovasc Pharmacol; 2003 Oct; 42(4):491-6. PubMed ID: 14508234 [TBL] [Abstract][Full Text] [Related]
10. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
11. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies. Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855 [TBL] [Abstract][Full Text] [Related]
12. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I). Williams B; Gosse P; Lowe L; Harper R; J Hypertens; 2006 Jan; 24(1):193-200. PubMed ID: 16331118 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients. Krum H; Nolly H; Workman D; He W; Roniker B; Krause S; Fakouhi K Hypertension; 2002 Aug; 40(2):117-23. PubMed ID: 12154100 [TBL] [Abstract][Full Text] [Related]
15. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. White WB; Lacourciere Y; Davidai G Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889 [TBL] [Abstract][Full Text] [Related]
16. Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril. Wang JG; Pimenta E; Chwallek F Vasc Health Risk Manag; 2014; 10():189-200. PubMed ID: 24741317 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. Williams B; Lacourcière Y; Schumacher H; Gosse P; Neutel JM J Hum Hypertens; 2009 Sep; 23(9):610-9. PubMed ID: 19225530 [TBL] [Abstract][Full Text] [Related]
18. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials. Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649 [TBL] [Abstract][Full Text] [Related]
19. Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies. Gosse P; Schumacher H Hypertens Res; 2014 Feb; 37(2):151-7. PubMed ID: 24048485 [TBL] [Abstract][Full Text] [Related]
20. Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring. Bakris G J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):26-31. PubMed ID: 12147926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]